Vitamin K and bone health

Nutrition

Volumn 17, Issue 10, 2001, Pages 880-887

  Weber, Peter ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Bone health; Bone mineral density; Fracture; Osteocalcin; Osteoporosis; Vitamin K

Indexed keywords

ANTIVITAMIN K; CALCIUM; FARNOQUINONE; OSTEOCALCIN; PHYTOMENADIONE; VITAMIN D; VITAMIN K GROUP;

BLOOD CLOTTING; BONE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE MINERALIZATION; CALCIUM BALANCE; CARBOXYLATION; CLINICAL TRIAL; DIETARY INTAKE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FRACTURE; HEALTH STATUS; HUMAN; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; ORGANIZATION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TYPES OF STUDY; VITAMIN SUPPLEMENTATION;

EID: 0034772742     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(01)00709-2     Document Type: Article

References (82)

1. Clinical application of bone densitometry
2. How many women have osteoporosis now?
3. Optimal calcium intake
4. The worldwide problem of osteoporosis: Insights afforded by epidemiology
5. The future of hip fractures in the United States
6. Epidemiology of osteoporosis
7. Nutrition in bone health revisited: A story beyond calcium
8. A high ratio of dietary animal to vegetable protein increases the rate of bone loss and risk of fracture in postmenopausal women
9. Protein intake and bone health: The influence of believe systems
10. Nutrition, and Osteoporosis
11. Bone health: The role of micronutrients
12. The role of vitamins in the prevention of osteoporosis - A brief status report
13. Nutrition, life style and quality of life
14. Chemistry, nutritional sources, tissue distribution amd metabolism of vitamin K with special reference to bone health
15. 2 (menaquinone) in the Netherlands
16. Nutritional sources of vitamin K
17. The importance of menaquinones in human nutrition
18. Vitamin K
19. The vitamin K-dependent carboxylase
20. The vitamin K-dependent proteins: An update
21. Physiological importance of extra-hepatic vitamin K-dependent carboxylation reactions
22. Vitamin K-dependent carboxylase
23. Vitamin K nutrition and osteoporosis
24. GLA-containing proteins
25. GLA-containing proteins of bone
26. Increased bone formation in osteocalcin-deficient mice
27. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin
28. Biochemical markers of bone turnover
29. Vitamin K supplementation reduces serum concentration of under-gamma-carboxylated osteocalcin in healthy young and elderly adults
30. Vitamin K
31. Dietary induced subclinical vitamin K deficiency in normal human subjects
32. b in growing and ovariectomized rats
33. The effect of diet on blood vitamin K status and urinary mineral excretion assessed by a food questionnaire
34. Effect of gamma-glutamyl carboxylation of renal microsomes on calcium oxalate monohydrate crystal binding in hyperoxaluria
35. Vitamin K2 promotes 1-alpha,25(OH)-2 vitamin D-3-induced mineralization in human periosteal osteoblasts
36. Influence of vitamin D3 on inhibitory effect of vitamin K2 on bone loss in ovariectomized rats
37. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss
38. Vitamin K2 (menatetrenon) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity
39. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds
40. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis
41. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck
42. Serum vitamin K level and bone mineral density in post-menopausal women
43. 2 decreased in elderly women with hip fracture
44. Participation of decreased circulating levels of vitamin K in bone mineral loss of elderly men
45. Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteoporotic elderly men
46. Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study
47. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
48. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Another pathogenetic factor of osteoporosis in Crohn's disease?
49. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
50. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study
51. Carboxylation of osteocalcin may be related to bone quality: A possible mechanism of bone fracture prevention by vitamin K
52. Vitamin K intake and hip fractures in women: A prospective study
53. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women
54. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk
55. Warfarin use and risk for osteoporosis in elderly women
56. Taux d'osteocalcine et masse osseuse chez les patients recevant des antivitamines K
57. Vitamin K and maintenance of skeletal integrity in adults
58. Normal cortical bone mass in patients after long term coumadin therapy
59. Long-term use of oral anticoagulants and the risk of fracture
60. Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon
61. Heparins, coumarin, and bone density
62. Reduced bone mineral content in patients taking an oral anticoagulant
63. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects
64. Impaired carboxylation of serum osteocalcin in elderly women: Effect of vitamin K1 treatment
65. Space flight is associated with rapid decrease of undercarboxylated osteocalcin and increases of markers of bone resorption without changes in their circadian variation: Observations in two cosmonauts
66. Improved bone metabolism in female elite athletes after vitamin K supplementation
67. 1 supplementation of Dutch postmenopausal women with normal and low bone mineral densities: Effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin
68. Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation
69. Effect of vitamin K and or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures
70. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion
71. 3
72. Vitamin K (K) increased bone mass (BM) in hemo-dialysis patients (pts) with low-turnover bone disease
73. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients
74. Short-trem effect of vitamin K administration on prednisolone-induced bone loss of bone mineral density in patients with chronic glomerulonephritis
75. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis
76. Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide
77. A one-year randomized controlled trial of hormone replacement therapy, bisphosphonate, calcitonin, vitamin D and vitamin K in women with postmenopausal osteoporosis
78. Vitamin K2 (Menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
79. Two-year intervention with phylloquinone (vitamin K1), vitamin D and calcium effect on bone mineral content of older women
80. Effects of menatetrenone on the bone and calcium in osteoporosis: A double-blind pacebo-controlled study
81. Vitamin K